Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications

Systemic juvenile idiopathic arthritis (SJIA) is a chronic arthritis of children characterized by a combination of arthritis and systemic inflammation. There is usually non-specific laboratory evidence of inflammation at diagnosis but no diagnostic test. Normalized volumes from 89/889 2-D protein sp...

Full description

Saved in:
Bibliographic Details
Published inProteomics (Weinheim) Vol. 10; no. 24; pp. 4415 - 4430
Main Authors Ling, Xuefeng B, Park, Jane L, Carroll, Tanya, Nguyen, Khoa D, Lau, Kenneth, Macaubas, Claudia, Chen, Edward, Lee, Tzielan, Sandborg, Christy, Milojevic, Diana, Kanegaye, John T, Gao, Susanna, Burns, Jane, Schilling, James, Mellins, Elizabeth D
Format Journal Article
LanguageEnglish
Published Weinheim Wiley-VCH Verlag 01.12.2010
WILEY-VCH Verlag
WILEY‐VCH Verlag
Wiley-VCH
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Systemic juvenile idiopathic arthritis (SJIA) is a chronic arthritis of children characterized by a combination of arthritis and systemic inflammation. There is usually non-specific laboratory evidence of inflammation at diagnosis but no diagnostic test. Normalized volumes from 89/889 2-D protein spots representing 26 proteins revealed a plasma pattern that distinguishes SJIA flare from quiescence. Highly discriminating spots derived from 15 proteins constitute a robust SJIA flare signature and show specificity for SJIA flare in comparison to active polyarticular juvenile idiopathic arthritis or acute febrile illness. We used 7 available ELISA assays, including one to the complex of S100A8/S100A9, to measure levels of 8 of the15 proteins. Validating our DIGE results, this ELISA panel correctly classified independent SJIA flare samples, and distinguished them from acute febrile illness. Notably, data using the panel suggest its ability to improve on erythrocyte sedimentation rate or C-reactive protein or S100A8/S100A9, either alone or in combination in SJIA F/Q discriminations. Our results also support the panel's potential clinical utility as a predictor of incipient flare (within 9 wk) in SJIA subjects with clinically inactive disease. Pathway analyses of the 15 proteins in the SJIA flare versus quiescence signature corroborate growing evidence for a key role for IL-1 at disease flare.
Bibliography:http://dx.doi.org/10.1002/pmic.201000298
ArticleID:PMIC201000298
Lucille Packard Foundation for Children's Health Initiative
ark:/67375/WNG-TZM651LR-Z
Colour Online: See the article online to view Figs. in colour.
The Wasie Foundation
National Institute of Arthritis and Musculoskeletal and Skin Diseases - No. T32AR050942
NIH
American College of Rheumatology Research and Education Physician Scientist Development Award
istex:67FFB666F7DAFABFC30E52EC0F4A13EC68157CB1
Dana Foundation
See the article online to view Figs. in colour.
These authors have contributed equally to this work.
Colour Online
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
These authors contributed equally to this work.
ISSN:1615-9853
1615-9861
1615-9861
DOI:10.1002/pmic.201000298